We further found that BIX reduced BCKDHA mRNA and protein levels only in EGFR-mutant NSCLC cells, indicating that this small molecule inhibitor affects BCAA metabolism in these NSCLC cells (Fig. 3f, g). Here, BCKDHA is linked to non-small cell lung carcinoma.